These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10676 related articles for article (PubMed ID: 10935469)

  • 1. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.
    Ramirez RD; D'Atri S; Pagani E; Faraggiana T; Lacal PM; Taylor RS; Shay JW
    Neoplasia; 1999 Apr; 1(1):42-9. PubMed ID: 10935469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
    Guttman-Yassky E; Bergman R; Manov L; Sprecher E; Shaefer Y; Kerner H
    J Cutan Pathol; 2002 Jul; 29(6):341-6. PubMed ID: 12135464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
    Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
    Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
    Miracco C; Margherita De Santi M; Schürfeld K; Santopietro R; Lalinga AV; Fimiani M; Biagioli M; Brogi M; De Felice C; Luzi P; Andreassi L
    Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of telomerase activity in cutaneous melanocytic proliferations.
    Miracco C; Pacenti L; Santopietro R; Laurini L; Biagioli M; Luzi P
    Hum Pathol; 2000 Sep; 31(9):1018-21. PubMed ID: 11014565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of human telomerase RNA expression in situ in malignant melanoma].
    Wei Q; Fen S
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):107-9. PubMed ID: 11938761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
    Kuźbicki L; Sarnecka A; Chwirot BW
    Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
    Pathak S; Multani AS; McConkey DJ; Imam AS; Amoss MS
    Int J Oncol; 2000 Dec; 17(6):1219-24. PubMed ID: 11078808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions.
    Kuźbicki L; Aładowicz E; Chwirot BW
    Melanoma Res; 2006 Oct; 16(5):435-44. PubMed ID: 17013093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
    Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
    J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions.
    Singh RS; Diwan AH; Zhang PS; Prieto VG
    J Cutan Pathol; 2007 Mar; 34(3):220-5. PubMed ID: 17302605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase Expression in a Series of Melanocytic Neoplasms.
    de Unamuno Bustos B; Sahuquillo Torralba A; Moles Poveda P; Pérez Simó G; Simarro Farinos J; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):212-219. PubMed ID: 30591199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase II-alpha expression in melanocytic nevi and malignant melanoma.
    Mu XC; Tran TA; Ross JS; Carlson JA
    J Cutan Pathol; 2000 May; 27(5):242-8. PubMed ID: 10847549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Chwirot BW; Kuźbicki Ł
    Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
    Vagner J; Steiniche T; Stougaard M
    Histopathology; 2015 Apr; 66(5):747-51. PubMed ID: 25601620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 534.